ATE522520T1 - Neues syntheseverfahren für fluorquinolone - Google Patents
Neues syntheseverfahren für fluorquinoloneInfo
- Publication number
- ATE522520T1 ATE522520T1 AT08104076T AT08104076T ATE522520T1 AT E522520 T1 ATE522520 T1 AT E522520T1 AT 08104076 T AT08104076 T AT 08104076T AT 08104076 T AT08104076 T AT 08104076T AT E522520 T1 ATE522520 T1 AT E522520T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- compound
- nrr1a
- optionally substituted
- formula
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- -1 quinoline compound Chemical class 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 229940124307 fluoroquinolone Drugs 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 150000004677 hydrates Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 101710137619 DNA gyrase inhibitor Proteins 0.000 abstract 1
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 abstract 1
- 239000000317 Topoisomerase II Inhibitor Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002271 gyrase inhibitor Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000007524 negative regulation of DNA replication Effects 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0755240A FR2916446B1 (fr) | 2007-05-24 | 2007-05-24 | Nouveau procede de synthese de fluoroquinolones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522520T1 true ATE522520T1 (de) | 2011-09-15 |
Family
ID=38935887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08104076T ATE522520T1 (de) | 2007-05-24 | 2008-05-23 | Neues syntheseverfahren für fluorquinolone |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8093381B2 (de) |
| EP (1) | EP2138490B1 (de) |
| JP (1) | JP5373320B2 (de) |
| CN (1) | CN101337934A (de) |
| AT (1) | ATE522520T1 (de) |
| ES (1) | ES2372885T3 (de) |
| FR (1) | FR2916446B1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101759629B (zh) * | 2009-12-22 | 2012-01-11 | 北大方正集团有限公司 | 西他沙星中间体的制备方法 |
| CN101768167B (zh) * | 2010-01-15 | 2012-07-04 | 浙江东亚药业有限公司 | 左氧氟沙星的缩哌合成方法 |
| CN101792443A (zh) * | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
| CN102827143A (zh) * | 2012-08-14 | 2012-12-19 | 安徽赛诺医药化工有限公司 | 一种合成氟喹诺酮及其盐的新方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53141286A (en) | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| SE440354B (sv) | 1981-02-19 | 1985-07-29 | Kyorin Seiyaku Kk | Kinolinkarboxylsyraderivat |
| GB2095171A (en) * | 1981-02-27 | 1982-09-29 | Ushio Electric Inc | Apparatus for heat-laminating a sheet |
| US4665079A (en) | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
| US4473568A (en) | 1983-03-01 | 1984-09-25 | Warner Lambert Company | Antibacterial thiazolidine or thiomorpholine substituted quinolines |
| AU553415B2 (en) | 1983-09-19 | 1986-07-17 | Abbott Japan Co., Ltd. | 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids |
| EP0230053A3 (de) | 1986-01-17 | 1988-03-30 | American Cyanamid Company | 7-(Substituierte)Piperazinyl-1-äthyl-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarbonsäure |
| EP0329719A1 (de) | 1987-06-24 | 1989-08-30 | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. | Verfahren zur herstellung von chinolincarbonsäure abkömmlingen |
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| JPH0794452B2 (ja) * | 1987-10-16 | 1995-10-11 | 大日本製薬株式会社 | 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩 |
| JPH02231424A (ja) * | 1988-10-17 | 1990-09-13 | Dainippon Pharmaceut Co Ltd | 抗菌剤 |
| DE3918544A1 (de) * | 1989-06-07 | 1990-12-13 | Bayer Ag | Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren |
| DE4342186A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten |
| GB2291421A (en) * | 1994-07-16 | 1996-01-24 | Pfizer | A process for preparing a quinoline carboxylic acid |
| WO2003010144A2 (en) * | 2001-07-25 | 2003-02-06 | Farmaceutsko-Hemijska Industrija 'zdravlje' | A process for synthesis of fluoroquinolonic derivatives |
-
2007
- 2007-05-24 FR FR0755240A patent/FR2916446B1/fr not_active Expired - Fee Related
-
2008
- 2008-05-22 US US12/125,434 patent/US8093381B2/en active Active
- 2008-05-23 ES ES08104076T patent/ES2372885T3/es active Active
- 2008-05-23 CN CNA200810098225XA patent/CN101337934A/zh active Pending
- 2008-05-23 AT AT08104076T patent/ATE522520T1/de not_active IP Right Cessation
- 2008-05-23 JP JP2008135975A patent/JP5373320B2/ja not_active Expired - Fee Related
- 2008-05-23 EP EP08104076A patent/EP2138490B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2372885T3 (es) | 2012-01-27 |
| EP2138490A1 (de) | 2009-12-30 |
| US20090054643A1 (en) | 2009-02-26 |
| JP5373320B2 (ja) | 2013-12-18 |
| US8093381B2 (en) | 2012-01-10 |
| FR2916446A1 (fr) | 2008-11-28 |
| FR2916446B1 (fr) | 2009-08-21 |
| EP2138490B1 (de) | 2011-08-31 |
| JP2009001560A (ja) | 2009-01-08 |
| CN101337934A (zh) | 2009-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1781683T3 (pl) | Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich | |
| AR060489A1 (es) | Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol | |
| MA29464B1 (fr) | Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues | |
| BRPI0715691B8 (pt) | método para a produção de ácido acético | |
| MX2014006992A (es) | Disales de acido malonico y metodo para preparar dihaluros de malonilo. | |
| WO2008126943A3 (en) | Method for manufacturing neuraminic acid derivatives | |
| SI2285765T1 (sl) | Postopek priprave derivatov 1-(2-halobifenil-4-il)-ciklopropankarboksilne kisline | |
| FR2916446B1 (fr) | Nouveau procede de synthese de fluoroquinolones | |
| AR075915A1 (es) | Proceso para la obtencion de derivados de acido propionico | |
| UA111868C2 (uk) | Спосіб одержання естерів (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)-оцтової кислоти | |
| BR112014014635A2 (pt) | método para fabricar um composto, e, composto | |
| FR2970254B1 (fr) | Procede de preparation de carbonate d'alcool | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| ATE532516T1 (de) | Verfahren zur synthese von glyt-1-hemmern | |
| PL1902036T3 (pl) | Sposób wytwarzania rosuwastatyny i związki pośrednie | |
| CO6612175A2 (es) | Metodo para producir 4,6-dialcoxi-2-cianometil-pirimidina e intermediarios sinteticos de esta | |
| WO2015022702A3 (en) | Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof | |
| DE602007002486D1 (de) | Verfahren zur herstellung von 1-halogen-2,7-naphthyridinylderivaten | |
| DE602006020196D1 (de) | Verfahren zur herstellung einer 3-o-alkylascorbinsäure | |
| AR051936A1 (es) | Proceso para la preparacion de pirazoles | |
| BRPI0909752A2 (pt) | método para a produção de sulfonilpirróis como inibidores de hdac | |
| DE602006015458D1 (de) | Verfahren zur herstellung eines carbonsäureamidderivats | |
| EP1728787A4 (de) | Verfahren zur aufreinigung von 2-chlor-5-chlormethyl-1,3-thiazol | |
| DE602007000211D1 (de) | Verfahren zur Gewinnung eines zur Gewinnung von Valsartan nützlichen Valsartan-Salzes | |
| AR077506A1 (es) | Sintesis enantio y estereo- especificas de beta-amino-alfa-hidroxiamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |